Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement

Clinical Endocrinology

Volumn 65, Issue 5, 2006, Pages 673-680

  Brooke, Antonia M ^a   Kalingag, Leonila A ^a   Miraki Moud, Farideh ^a   Camacho Hübner, Cecilia ^a   Maher, Katharine T ^a   Walker, Dorothy M ^a   Hinson, Joy P ^a   Monson, John P ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ESTROGEN; FOLLITROPIN; INSULIN; LIPOPROTEIN; LUTEINIZING HORMONE; PLACEBO; PRASTERONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; BONE REMODELING; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GREASY HAIR; GREASY SKIN; HAIR DISEASE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INSULIN SENSITIVITY; IRRITABILITY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP PRURITUS; SKIN DISEASE; SWEATING; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

ADULT; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; CHOLESTEROL, HDL; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; TIME FACTORS; TRIGLYCERIDES;

EID: 33750037908     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02648.x     Document Type: Article

References (31)

1. Weaver, J.U., Thaventhiran, L., Noonan, K., Burrin, J.M., Taylor, N.F., Norman, M.R. & Monson, J.P. (1994) The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology, 41, 639-648.
2. Gelding, S.V., Taylor, N.F., Wood, P.J., Noonan, K., Weaver, J.U., Wood, D.F. & Monson, J.P. (1998) The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity. Clinical Endocrinology, 48, 153-162.
3. Moore, J.S., Monson, J.P., Kaltsas, G., Putignano, P., Wood, P.J., Sheppard, M.C., Besser, G.M., Taylor, N.F. & Stewart, P.M. (1999) Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism, 84, 4172-4177.
4. Toogood, A.A., Taylor, N.F., Shalet, S.M. & Monson, J.P. (2000) Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. Journal of Clinical Endocrinology and Metabolism, 85, 1727-1730.
5. Trainer, P., Drake, W., Taylor, N., Besser, G. & Monson, J.P. (2001) Modulation of cortisol metabolism by the growth hormone receptor antagonist, pegvisomant. Journal of Clinical Endocrinology and Metabolism, 86, 2989-2992.
6. Isidori, A.M., Kaltsas, G.A., Perry, L., Burrin, J.M., Besser, G.M. & Monson, J.P. (2003) The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. Clinical Endocrinology, 58, 601-611.
7. Span, J.P.T., Pieters, G., Sweep, C., Hermus, A. & Smals, A. (2000) Gender difference in insulin-like growth factor-I response to growth hormone (GH) treatment in GH-deficient adults: Role of sex hormone replacement. Journal of Clinical Endocrinology and Metabolism, 85, 1121.
8. Arlt, W., Justl, H.-G., Callies, F., Reincke, M., Hubler, D., Oettel, M., Ernst, M., Schulte, H.M. & Allolio, B. (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and oestrogens in young females after dexamethasone suppression. Journal of Clinical Endocrinology and Metabolism, 83, 1928-1934.
9. Gebre-Medhin, G., Husebye, E., Mallmin, H., Helström, L., Berne, C., Karrisson, F.A. & Kämpe, O. (2000) Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. Clinical Endocrinology, 52, 775-780.
10. Hunt, P., Gurnell, E., Huppert, F., Richards, C., Prevost, A.T., Wass, J.A.H., Herbert, J. & Chatterjee, V.K.K. (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. Journal of Clinical Endocrinology and Metabolism, 85, 4650-4656.
11. Arlt, W., Callies, F., Van Vlijem, J.C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettal, M., Ernst, M., Schulte, H.M. & Allolio, B. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England Journal of Medicine, 341, 1013-1020.
12. Løvås, K., Gebre-Medhin, G., Trovik, T., Fougner, K.J., Uhlving, S., Nedrebø, B.G., Myking, O.L., Kämpe, O. & Husebye, E.S. (2003) Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. Journal of Clinical Endocrinology and Metabolism, 88, 1112-1118.
13. Johannsson, G., Burman, P., Wirén, L., Engström, B.E., Nilsson, A.G., Ottosson, M., Jonsson, B., Bengtsson, B.A. & Karlsson, F.A. (2002) Low dose dehydroepiandrosterone affects behaviour in hypopituitary androgen-deficient women: a placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 87, 2046-2052.
14. van Thiel, S.W., Romijn, J.A., Pereira, A.M., Biermasz, N.R., Roelfsema, F., van Hernert, A., Ballieux, B. & Smit, J.W.A. (2005) Effects of DHEA, superimposed on growth hormone substitution, on quality of life and IGF-I in patients with secondary adrenal insufficiency: a randomised, placebo controlled, crossover trial. Journal of Clinical Endocrinology and Metabolism, 90, 3295-3303.
15. Young, J., Couzinet, B., Nahoul, K., Brailly, S., Chanson, P., Baulieu, E.E. & Schaison, G. (1997) Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. Journal of Clinical Endocrinology and Metabolism, 82, 2578-2585.
16. Morales, A.J., Nolan, J.J., Nelson, J.C. & Yen, S.S.C. (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. Journal of Clinical Endocrinology and Metabolism, 78, 1360-1367.
17. Matthews, D., Hosker, J., Rudenski, A., Naylor, B., Tracher, D. & Turner, R. (1985) Homeostasis model of assessment; insulin resistance and β cell function from plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
18. Morrell, D.J., Dadi, H., More, J., Taylor, A.M., Dabestani, A., Buchanan, C.R., Holder, A.T. & Preece, M.A. (1989) A monoclonal antibody to human insulin-like growth factor-I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor. Journal of Molecular Endocrinology, 2, 201-206.
19. Lie, R., Schmidt, J., Pierre, K. & Gochman, N. (1976) Cholesterol oxidase based determination by continuous-flow analysis of total and free cholesterol in serum. Clinical Chemistry, 22, 1627.
20. Lopez-Virella, M., Stone, P., Ellis, S. & Colvell, J. (1977) Cholesterol oxidase based determination by continuous-flow analysis of total and free cholesterol in serum. Clinical Chemistry, 23, 882-884.
21. Fossati, P. & Prencipe, L. (1982) Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry, 28, 2077.
22. Friedewald, W., Levy, R. & Fredrickson, D. (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clinical Chemistry, 18, 439-502.
23. Drake, W.M., Coyte, D., Camacho-Hubner, C., Jivanji, N.M., Kaltsas, G., Wood, D.F., Trainer, P.J., Grossman, A.B., Besser, G.M. & Monson, J.P. (1998) Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 83, 3913-3919.
24. Dhatariya, K., Bigelow, M. & Sreekumaran Nair, K. (2005) Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes, 54, 765-769.
25. Callies, F., Fassnacht, M., Van Vlijmen, J., Koehler, I., Huebler, D., Seibel, M.J., Arlt, W. & Allolio, B. (2001) Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. Journal of Clinical Endocrinology and Metabolism, 86, 1968-1972.
26. Christiansen, J., Gravholt, C., Fisker, S., Møller, N., Anderson, M., Svenstrup, B., Bennett, P., Ivarsen, P., Christiansen, J.S. & Jørgensen, J.O.L. (2005) Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism. European Journal of Endocrinology, 152, 77-85.
27. Lasco, A., Frisina, N., Morabito, N., Gaudio, A., Morini, E., Trifiletti, A., Basile, G., Nicita-Mauro, V. & Cucinotta, D. (2001) Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. European Journal of Endocrinology, 145, 457-461.
28. Kawano, H., Yasue, H., Kitagawa, A., Hirai, N., Yoshida, T., Soejima, H., Miyamoto, S., Nakano, M. & Ogawa, H. (2003) Dehydroepiandrosterone improves endothelial function and insulin sensitivity in men. Journal of Clinical Endocrinology and Metabolism, 88, 3190-3195.
29. Morales, A.J., Haubrich, R., Hwang, J., Asakura, H. & Yen, S. (1998) The effects of 6 months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clinical Endocrinology, 49, 421-432.
30. Nestler, J., Barlascini, C., Clore, J. & Blackard, W. (1988) Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. Journal of Clinical Endocrinology and Metabolism, 66, 57-61.
31. Mortola, J. & Yen, S. (1990) The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in post-menopausal women. Journal of Clinical Endocrinology and Metabolism, 71, 696-704.